Trials / Completed
CompletedNCT01148433
Quality of Life With TESTIM®
Quality of Life With TESTIM® in Testosterone Replacement Therapy for Male Patients With Hypogonadism
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 157 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The present non-interventional study is to document the testosterone levels in patients with clinical symptoms such as loss of sexual desire indicating hypogonadism (testosterone deficiency syndrome). During testosterone replacement therapy with TESTIM®, the changes in the quality of life - especially with respect to motivation, activity and fatigue - of hypogonadal patients will be documented and correlated with the testosterone levels during the course of therapy.
Conditions
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2011-06-01
- Completion
- 2011-07-01
- First posted
- 2010-06-22
- Last updated
- 2011-12-22
Locations
64 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01148433. Inclusion in this directory is not an endorsement.